{"schema":"hottub-news/story/v1","story":"st_ompw4ih7sd54osqgne6q","title":"Samsung Bioepis, Teva enter commercialization agreement on 6 biosimilar candidates","title_en":null,"outlets":2,"brief":null,"page":"https://hottub.news/stories/samsung-bioepis-and-teva-expand-strategic-partnership-to-advance-up-to-ompw4ih7sd","count":2,"items":[{"id":"n_oyzqmmbaztrekne2v3lq","seq":1095837,"kind":"article","title":"Samsung Bioepis, Teva enter commercialization agreement on 6 biosimilar candidates","url":"https://www.koreatimes.co.kr/business/companies/20261001/samsung-bioepis-teva-enter-commercialization-agreement-on-6-biosimilar-candidates","summary":"Samsung Bioepis and Teva Pharmaceutical Industries have entered into an agreement on commercializing the former’s up to six potential biosimilar candidates, including two confirmed investigational candidates, the companies said Thursday. According to Samsung Bioepis, the two sides have signed a global licensing, development and commercialization agreement for the potential candidates. Of them, two confirmed investigational biosimilar candidates are SB41, referencing…","published":"2026-10-01T09:12:03Z","seen":"2026-10-01T09:14:13Z","lang":"en","source":{"id":"kite-koreatimes-co-kr-c6eccf","name":"koreatimes.co.kr","domain":"feed.koreatimes.co.kr"},"via":"kite-koreatimes-co-kr-c6eccf","topics":["asia"],"authors":["author"],"entities":[{"id":"Q16920038","name":"SAMSUNG BIOEPIS","type":"org"},{"id":"Q2868194","name":"World Esperantist Vegetarian Association","type":"org"}],"image":"https://newsimg.koreatimes.co.kr/2026/10/01/6b66b216-de07-4335-86ec-d79e53883e1f.jpg","story":"st_ompw4ih7sd54osqgne6q","category":"economy-business","category_p":0.3799999952316284,"category2":"science-technology","sentiment":"positive","tone":0.3499999940395355,"political":0.10999999940395355},{"id":"n_ompw4ih7sd54osqgne6q","seq":1113948,"kind":"article","title":"Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates","url":"https://www.intelligencer.ca/press-releases/business-wire/samsung-bioepis-and-teva-expand-strategic-partnership-to-advance-up-to-six-potential-biosimilar-candidates","published":"2026-10-01T08:32:00Z","seen":"2026-10-01T10:38:45Z","lang":"en","country":"CA","source":{"id":"intelligencer.ca","name":"intelligencer.ca","domain":"intelligencer.ca","outlet":{"wikidata":"Q4883859","name":"Belleville Intelligencer","type":"magazine","country":"CA","designations":["periodical"]}},"via":"gdelt-gkg-english","topics":["economy","business","health"],"authors":["Business Wire"],"entities":[{"id":"Q16920038","name":"SAMSUNG BIOEPIS","type":"org"},{"id":"Q2868194","name":"World Esperantist Vegetarian Association","type":"org"}],"story":"st_ompw4ih7sd54osqgne6q","category":"science-technology","category_p":0.49000000953674316,"category2":"health","sentiment":"positive","tone":0.6000000238418579,"political":0.05000000074505806}]}